Latest news with #Groupon
Buzz Feed
a day ago
- General
- Buzz Feed
43 Products That Work So Well, You'll Want To Throw Them A Party To Celebrate
A set of legging hangers that are about to be an organizational game-changer for Lulu fanatics. These will each keep 10 of your go-to leggings within easy reach, so no more rummaging around in a crowded drawer to find your fave pair. Gold Bond's firming neck and chest cream, because your décolletage deserves some special skincare attention. It contains salicylic acid to gently exfoliate dead skin cells, while glycerin and aloe add some extra hydration. Put that Groupon for a laser treatment down — try this first! A Pikk-it tool designed to remove the tangled hair/fur that's lodged in your vacuum's roller brush (which is making it WAY less effective, btw). You can also use it to spruce up your hairbrushes, so this is basically stray hair's worst enemy. A grape cutter that makes quartering grapes (or cherry tomatoes!) an absolute breeze — so it's perfect for anyone whose knife skills need a little work. Just insert your grape, push down on the plunger and — voila! — you'll have perfectly cut slices. Best of all, it's super easy to take apart so you can pop it in the dishwasher. FryAway Waste Cooking Oil Solidifier Powder — it turns hot grease and oil into a solid substance you can easily scrape away from the pan and into the trash. No more wondering what on earth you're going to do with that brown sludge that's left behind 😬. A CeraVe eye cream that uses the power of hyaluronic acid and ceramides to hydrate and smooth the delicate skin under your eyes, including fine lines. The fragrance-free formula makes it perfect for sensitive skin, and reviewers say it works wonderfully under concealer. The Catrice "Instant Awake" Under Eye Brightener, which will have you singing 🎵 "where have you been all my li-i-i-i-i-ife?" 🎵 on those busy mornings when you need to look like you got a full eight hours of sleep. Reviewers say it blends seamlessly into the skin and adds light coverage to dark circles — and it now comes in four shades! A ceiling fan carbon filter made of coconut shell carbon, which is brilliant at helping trap dust, pollen, dirt, and other allergens that float around your home. They're also super easy to install — just remove the adhesive strip and place on the top of your fan's blades. A genius brush and squeegee combo so you can swipe all your countertop messes directly into the sink. It even has a built-in ledge so you can hang it when not in use. You'll have your countertops looking dry and spotless in just a few swipes! The gentle LilyAna Naturals retinol cream because retinol is the GOAT when it comes to smoothing fine lines and firming your skin. This super popular cream (peep the 26,000+ five-star reviews 👀) also features hyaluronic acid and shea butter to moisturize, as well as aloe to soothe. And a retinol body lotion — the magic of retinol is not just for your face! This retinol in the creamy formula helps promote skin cell turnover, while the ferulic acid firms skin for a tighter appearance. Reviewers also note that this works wonders on rough, bumpy skin on their upper arms and legs after consistent use. And! The best-selling Sol De Janeiro Bum Bum Cream that not only smells like caramel and pistachio deliciousness (pair it with the matching body mist to make the fragrance last even longer) but also can help tighten and firm the skin with repeated use thanks to the inclusion of caffeine-rich guarana extract. A rapid mac 'n' cheese cooker, which will make you turn your back on your stovetop for good. Instead of spending forever waiting for water to boil, you can just pop this in the microwave and discover the true definition of easy mac. A color-changing moisture indicator you can stick in your plant's soil so you can easily keep track of when your green baby needs a good watering. This little leaf-shaped wonder starts out white, turns green once the plant is watered, then turns white again when the soil is dry. Just imagine yourself surrounded by luscious, THRIVING plants!!! An Angry Orange pet odor eliminator — it eliminates the ~stank~ from everything from dirty carpets to nasty trash cans. It also couldn't be easier to use: just spray it on and let it break down those odors while leaving behind a delicious citrusy scent. John Frieda Frizz Ease Dream Curls Air Dry Waves Styling Foam for anyone who wants to define their curls without spending a ton of extra time. Just scrunch this through wet hair and then air-dry your way to perfectly wavy strands. A 3-in-1 gap cleaning brush — it'll clean all the nooks, crannies, and crevices on your water bottle that you didn't even know were there. Use the U-shaped silicone brush to quickly scrub around the lip of the cup, then flip over to the bristle brush to clean the lid (or pop up the hook brush to really get into those tough-to-reach grooves). A pair of handheld scrapers that will make your cast iron pans look as good as the day you bought them. It's gentle enough to use on nonstick surfaces, and unlike a sponge, this won't trap a bunch of food particles that are hard to rinse out. Now you can spend less time cleaning and more time whipping up culinary masterpieces. A Hanalei overnight lip treatment packed with Hawaiian kukui nut oil, agave, and grapeseed oils to hydrate and smooth away the dead skin that makes your lips look extra crusty. It's a must-have for anyone whose lips stay chapped. Plus, imagine how smoothly your fave lipstick will apply after using this! A bottle of earwax removal drops that use fizzy microfoam action to break down all the stubborn wax that was clogging up your ears for all of 2024. Just apply five to 10 drops to your ear, keep your head tilted for several minutes to let the carbamide peroxide loosen your hardened ear wax, then flush away any remaining wax with warm water in a bulb or syringe. A jar of all-in-one decor paint you can use on everything from kitchen cabinets to furniture upholstery. If there's a surface in your home that needs painting, this has got you covered. It dries in about 30 minutes and leaves behind a chalky matte finish that's the definition of country-chic. A hydrating Cosrx repairing essence with 96% snail secretion filtrate, which provides a gentle dose of moisture that won't overwhelm skincare newbies. Reviewers mention seeing a reduction in dark spots and acne. with consistent use, and even people with oily skin find that it absorbs quickly and doesn't clog their pores. Who knew snails had the secret to glassy, glowy skin this whole time?! A portable vacuum designed just for your car, because it's time to stop thinking to yourself, "I'll sweep these crumbs out eventually..." and actually get to cleaning. This plugs directly into your 12V outlet and comes with three attachments so you can clean everything from the floor mats to the scary cracks in between the seats. I Dew Care's dry shampoo powder that's so easy to use you'll wonder how you ever dealt with those messy spray cans. This one has a powder-puff applicator so you can apply it directly to roots (you know, the source of all your oily troubles), and it also adds some extra volume as you brush it through. Reviewers say it instantly absorbs oil and doesn't leave a white residue behind. And a root touchup powder so you can stretch the time between salon appointments. Just use the attached sponge to pick up some powder and rub it directly on any grays, or use it on your hairline to create a fuller appearance. It'll become one of your new beauty lifesavers — just ask the 16,000+ reviewers who left a perfect 5-star rating. Bissell's iconic Little Green cleaner — all the upholstery in your home is probably way overdue for a good cleaning, even if it doesn't look dirty. It's racked up a seriously impressive 69,000+ five-star reviews on Amazon so far, with many reviewers pointing out how lightweight and easy it is to use. Pet parents especially love it since it actually lifts all the stains that come along with having a fluffy friend in your home. An Anua pore-clearing cleansing oil that's specifically designed to help regulate your sebum production and break down blackheads, making it a great option for all my fellow oily-skinned peeps. It also helps break down makeup, so you can finally stop wasting money on makeup-removing wipes! And their 10% niacinamide serum — it'll help even your skin tone thanks to the blend of 4% tranexamic acid and 2% arbutin. Your skin will be left with a plump and dewy glow — and will also be grateful for the fragrance-free and non-sticky formula. A hairbrush cleaning tool because, as Xzibit might say, I heard you like brushes, so here's a brush to clean your brush. Yes, you should be giving your hairbrush a routine cleaning to remove hair, built-up oils, and grime — and this cleaning device makes it so easy to get into all the nooks and crannies. A satin-finish TirTir cushion foundation 9,000+ reviewers love for getting full coverage without the heavy, cakey feeling. It's designed to provide a radiant finish (hello, glass skin!), and reviewers say it pulls through on its long-lasting claims (up to 72 hours!). A tub of the TikTok-famous The Pink Stuff cleaning paste — which will take your sink, furniture, and tiles from grimy to shiny with the help of a little elbow grease. This will tackle any mess that pops up over the next 12 months. A pack of two dark spot corrector soap bars packed with tons of vitamin C and turmeric — aka the ultimate superhero ingredients for potentially brightening and reviving dull skin. Reviewers have had luck using this on both the face and body — but we recommend giving it a patch test first on a small area to see how your skin reacts. All good? Then start sudsing away! A toilet wand with disposable cleaning heads (the cleaning solution is built-in — just activate with water!) that makes scrubbing the porcelain throne feel like less of a chore. The kit comes with six refill heads (and a handy dandy storage stand for the wand and refills) to get you started, so you can immediately say goodbye to that dirty toilet brush and get to scrubbing in about 30 seconds! A gross but oh-so-satisfying Baby Foot exfoliating foot mask to remove all the dead skin that's lurking on your feet. Simply slip the booties on and let the fruit acid and 17 types of natural extracts get to work for an hour while you kick back. Then the fun part begins: your dead skin will start to peel off within five to seven days, revealing super smooth feet. A pomade hair wax stick — it'll be a major timesaver on those days when you want to smooth down flyaways, cowlicks, or set baby hairs into place. Just swipe it over any targeted areas you want to smooth and it'll provide some seriously strong hold without any sticky residue. You'll wish you had this back in the day when getting ready for school, but now your hair will finally hold up in windy weather! A heat-resistant masher that'll chop ground meat into tinier pieces, therefore greatly reducing your cooking time in the process. It's also perfect for crushing tomatoes, potatoes, and any other 'atoes that need mincing. A sleek automatic electric wine bottle opener because your day was stressful enough — you don't need a clunky corkscrew ruining your night! All you have to do is press it down over the top of the bottle, and there's even a built-in foil cutter so you won't ruin your nails in the process. Oh, and did I mention it's rechargeable and totally wireless?? A protective spray that creates an invisible coating on surfaces to prevent fingerprints, stains, smudges, soap scum, and more — so it's a must for all my fellow spill-prone people. It's safe for use on almost any hard surface, including granite counters, stainless steel, marble, porcelain, and glass — and the coating lasts for up to 12 months! O'Keeffe's Working Hands Cream, which will basically give you brand-new hands. Its blend of beeswax and glycerin will get your skin back to normal if the dry air has wreaked havoc on your hands over the last few months. A moisturizing hair serum from Korean hair care brand Mise En Scéne made with SEVEN nourishing oils: argan, coconut, jojoba, marula, olive, camelia, and apricot. They all work together to protect your strands from damage (including up to 446-degree heat protection!) while adding some hydration and shine. Kind of like how the seven members of S Club worked together to provide timeless bops. An over-the-drain hair catcher that'll collect all your loose strands in a tidy pile that's super easy to clean up. Reviewers say the silicone material helps keep it in place, and the drain holes are just big enough to let water through — meaning you won't be standing in a puddle of water by the end of your shower. A NYX Fat Oil lip gloss to douse your lips in hydrating raspberry seed oil while adding a super glowy shine and a light tint of color. Reviewers say this one combines the lightweight feel of a lip oil with the moisture of a heavier lip balm — and that it gives the way-more-expensive Dior lip oil a run for its money 👀. An absolutely genius tool that lets you easily spread butter on your pans before cooking or directly on hot foods like corn on the cob or fresh bread. No more ~butter fingers~!
Yahoo
3 days ago
- Business
- Yahoo
3 Surprising Stocks That Have More Than Doubled in 2025
Hims & Hers Health, FuboTV, and Groupon have all more than doubled in 2025. These companies took very different paths to their stellar year-to-date results. Hims & Hers Health has had to make some major changes to its business in recent months, but it's still positioned for healthy growth. 10 stocks we like better than Hims & Hers Health › This year has had its ups and downs on Wall Street, but some investments are rolling. There are 14 stocks with market caps north of $1 billion that have more than doubled so far in 2025 -- and some of the names will surprise you. Hims & Hers Health (NYSE: HIMS), FuboTV (NYSE: FUBO), and Groupon (NASDAQ: GRPN) -- yes, that Groupon -- are among those 14 stocks that have more than doubled their shareholder money this year. All three have taken entirely different routes to thumping the market this year. After it posted a whopping 183% gain last year, it wouldn't have been shocking to see Hims & Hers Health stock take a breather in 2025. The online healthcare platform that got its start by making it easier for people to secure prescriptions for erectile dysfunction drugs and hair growth treatments blew up last year due to the popularity of its compounded GLP-1 injectables for weight loss. Because Novo Nordisk (NYSE: NVO) was unable to produce Wegovy fast enough to meet surging demand, the Food and Drug Administration put the drug on its official shortage list. That opened up a legal loophole for businesses that operate as compounding pharmacies to produce and sell their own versions of the patented treatment. Hims & Hers cashed in with its own GLP-1 drug, featuring the same active ingredient found in Wegovy and Ozempic -- semaglutide. More importantly, it offered that treatment at more aggressive discounts than Novo Nordisk was putting on the name-brand versions. Hims & Hers Health was doing fine even before it hopped on the GLP-1 bandwagon in spring 2024. Its revenue has risen by at least 65% in each of the last six years. However, the popular new product helped it accelerate its top-line growth in 2024, and it continued to speed up in the first quarter of this year, when revenue more than doubled. This year began with early gains. Late in 2025, incoming President Donald Trump said he would tap Martin Makary to head the FDA. Makary served on the board of a company that also was into GLP-1 compounding, so the market took the view that Hims & Hers' upticks would continue even after Novo Nordisk finished ramping up Wegovy production to a level that could meet patient demand. Matters didn't exactly play out that way. Hims & Hers stock scored an all-time high on Feb. 19, but within weeks, the share price was cut by more than half. Novo Nordisk's production of semaglutide reached the volume necessary to close the FDA loophole, and it seemed as if the semaglutide compounding ride was ending for Hims & Hers and its peers. Then, two things happened that brought investors back. Novo Nordisk cut deals with a small number of telehealth companies, including Hims & Hers, giving them the right to sell discounted monthly subscriptions of Wegovy. Hims & Hers also reported a blowout first quarter earlier this month, and management forecast that the balance of its business outside of compounding would still grow at a healthy 30% clip this year. One of the first stocks to double in 2025 was FuboTV. The company behind the namesake sports-centric live TV streaming service more than tripled in the first week of trading after it struck a transformative deal with Disney (NYSE: DIS). Fubo had just 1.7 million paid subscribers heading into this year, less than 10% of the roughly 20 million households paying for live TV streaming services that digitally recreate versions of the familiar cable or satellite TV bundle. The stock entered this year trading 98% below the peak it touched in late 2020, when management had dreams of turning the company into a streaming platform with an online sportsbook component. Fubo had to fold that hand, but it still had an ace up its sleeve. Disney and two other media giants had been hoping to launch Venu Sports, a monthly subscription service that would bundle content from all of their sports properties -- anchored by Disney's majority-owned ESPN -- into a digital subscription costing $43 a month. But Fubo sued, and last summer, it won an injunction blocking Venu's launch. In a move to clear that obstacle, Disney offered to acquire a 70% stake in FuboTV. The House of Mouse will contribute its larger Hulu + Live TV service -- with 4.6 million subscribers -- to Fubo. Fubo will also receive $220 million from the Venu partners in exchange for dropping its lawsuit. The deal with Disney isn't expected to close until the the first half of next year, but if it falls apart, Fubo would collect another $130 million. It also has access to a $145 million term loan from Disney. Then something amusing happened. Within days of the deal that would give Disney a majority stake in Fubo but keep the smaller company's management in control, the three Venu partners decided not to go through with their digital bundle. Fubo has had its share of growing pains, but it's in an interesting win-win situation here. However, the shares have been meandering along at levels well below those they reached during that initial spike in January. Finally, we have a more conventional doubling chart. Groupon's rise this year can be traced to two specific events: the fourth-quarter earnings report it delivered in early March, and the first-quarter report it released earlier this month. After eight consecutive years of declining revenues, the online discounter of local experiences is starting to turn the corner. Revenue did decline 5% in Q4 2024, but gross billings for its flagship North American business climbed 8%. Its latest report showed even more improvement. Groupon posted a strong and unexpected profit. Analysts now predict it will make a return to revenue growth this year, and that its improvements will accelerate in 2026. Its business model could also prove to be attractive to lead-seeking businesses if the U.S. economy loses steam -- so don't discount this discounter. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $639,271!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $804,688!* Now, it's worth noting Stock Advisor's total average return is 957% — a market-crushing outperformance compared to 167% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Rick Munarriz has positions in Walt Disney. The Motley Fool has positions in and recommends Walt Disney and fuboTV. The Motley Fool has a disclosure policy. 3 Surprising Stocks That Have More Than Doubled in 2025 was originally published by The Motley Fool
Business Wire
3 days ago
- Business
- Business Wire
Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Tempus AI, Inc. (Nasdaq: TEM)
NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC ('Spruce Point' or 'we' or 'us'), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report entitled, 'The Tempest Surrounding Tempus AI', that outlines why we believe and estimate that shares of Tempus AI, Inc. (Nasdaq: TEM) ("Tempus" or the "Company") face up to 50% – 60% potential downside risk, or $26.35 – $32.95 per share. Download and view the report and its Full Legal Disclaimer by visiting for additional information and exclusive updates. Spruce Point Report Overview Tempus AI, Inc., (formerly Tempus Labs, Inc.) based in Chicago, IL, provides AI-enabled precision medicine solutions. The Company develops its diagnostics through the application of artificial intelligence in healthcare to make laboratory tests and connect lab results to a patient's clinical data. As of the last twelve months ended March 31, 2025, the Company reported approximately $803 million and ($77) million of revenue and Adjusted EBITDA, respectively. The concerns we outline in our report include: Tempus Founder Eric Lefkofsky and his associates have a history of promoting disruptive technology companies, cashing out early, and leaving public shareholders with losses or lackluster returns. Mr. Lefkofsky and his associate Bradley Keywell, who is also a major Tempus shareholder, have a history of partnering on companies that have ended poorly for public investors. The partners first sold to HA-LO Industries during the dot-com bubble which was blamed by some for sending HA-LO into bankruptcy. was positioned as the next but that concept never came to fruition and litigation emerged. The partners later co-founded Echo Global Logistics and Groupon. Groupon's struggles have been widely publicized, and despite Mr. Lefkofsky's claims that Groupon would be 'wildly profitable' and that some of its offerings could be positioned against Costco, its success was short-lived and its share price has declined -95% since its IPO. During the IPO process, Groupon also restated revenues by nearly 50% after encountering resistance from the SEC about its revenue recognition policy, and it reported a material weakness of internal controls after the IPO. Echo Global Logistics was touted as a technology disruptor in the freight and logistics market and also reported a material weakness of internal controls after its IPO. While public investors were ultimately rewarded with a takeover premium of +244% twelve years after its IPO, the stock vastly underperformed the Dow Jones Transportation Index by approximately 110% and the takeover came years after the partners ceased active involvement. Concerns around Tempus' AI capabilities are heightened given the minimal revenue generated from its AI applications. Amid the market enthusiasm for artificial intelligence, Tempus Labs rebranded as Tempus AI before its IPO. Despite its name, Tempus generated only $12.4 million, or 2% of total revenues, from AI applications in 2024. This time around, Mr. Lefkofsky makes aspirational claims to investors by tossing in comparisons such as Nvidia and Tesla. He suggests that Tempus is likely to reach a similar inflection point, and that vast upside is around the corner. However, ten years since being founded in 2015, there is no evidence that Tempus has generated a profit or net positive cash flow. In contrast, after a decade, both Nvidia and Tesla had already reached $2 billion in revenue (more than 2x TEM's revenue) and both were able to have at least one cash flow positive year. Our concerns about the Company's AI capabilities deepened after we evaluated split-second product demonstrations from promotional videos and screenshots from the Company's website. Apparently, Tempus has not properly figured out how to leverage AI to cross reference and check even basic facts such as patient age and the sequencing order of samples and deliveries. Multiple Board members and other executives have been associated with troubled companies that restated financial results. Tempus' Chief Financial Officer worked in a variety of accounting roles at Groupon, which, as we previously indicated, had challenges. The Chief Accounting Officer ('CAO') was previously CAO at RTI Medical (renamed: Surgalign) which had a multi-period financial restatement and resulted in revenue recognition fraud allegations by the SEC, though he was not specifically named in the compliant and some of the misconduct pre-dated his arrival. Tempus' Audit Chairman is the former CEO and Chairman of InnerWorkings, a company founded by Eric Lefkofsky, which restated results and disclosed a material weakness of controls shortly after his announced departure. Also on the audit committee is Peter Barris. Mr. Barris and his investment firm NEA were involved with Vonage Holdings and Neutral Tandem which rebranded as Inteliquent. Vonage, which was led by an SEC-charged executive named Jeffrey Citron, later restated its financials in 2008 while reporting a material weakness of internal controls. Inteliquent commenced an internal investigation of its financial reporting and accounting practices and reported a material weakness, but no restatement was made. Lastly, board member Ted Leonsis has partnered with Mr. Lefkofsky before at Groupon. His biography in Tempus' SEC filings fails to disclose he was Vice Chairman of AOL during a controversial period at the company and through its merger with Time Warner. Mr. Leonsis made a public statement that he was 'very comfortable' with the company's accounting practices. The SEC later charged eight executives with accounting fraud involving round tripping of revenue and imposed a $300 million civil penalty. Mr. Leonsis was not one of the executives charged. We see signs of aggressive accounting and financial reporting. The Company's revenue quality should be carefully scrutinized. To illustrate this, there is evidence of a well-timed announcement to support the Tempus equity story created by aggressive financial engineering and a suspicious joint venture ('JV') between Japan's SoftBank and Tempus ('SB Tempus'). The JV was announced on June 27, 2024, shortly after the IPO on June 14, 2024. A SoftBank affiliate invested $200 million in Tempus pre-IPO Series G-5 convertible preferred stock on April 30, 2024. Under the terms of the JV agreement, both Tempus and SoftBank each contributed ¥15.0 billion (approximately $95 million) to the joint venture. Tempus then recognizes revenue and other income from the JV over a 2- to 3-year period. This maneuver has the appearance of potentially round-tripping capital to create revenue and income for Tempus and undermines the credibility and substance of the arrangement. Curiously, the JV's recently appointed CEO departed within six months after the formation of the partnership. We believe the accounting treatment of the $250 million Google Cloud debt raises significant concerns about the quality of its Adjusted EBITDA and the Company's path to meeting its FY25 guidance. Specifically, Tempus nets the debt's principal modification against cloud and software expenses in SG&A based on usage. This non-cash operating benefit, totaling $25.6 million over the last twelve months, directly inflates reported Adj. EBITDA. Without this adjustment, LTM Adj. EBITDA would have been ($102.6) million, rather than the reported ($77.0) million, and Adj. EBITDA margin would be -320 bps lower. We do not know the exact usage mechanism driving the debt principal reduction, but Tempus could be creating a 'cookie jar' to achieve its inflection to $5 million of positive Adj. EBITDA for FY25. We believe the non-cash gain should be recorded as 'other income' instead of as an operating income benefit. We believe the Total Contract Value ('TCV') that Tempus reports is aggressively defined with non-binding opt-ins, improbable milestone payments, related-party transactions, and self-funded commitments. For example, $300 million in cumulative opt-ins and $22.4 million in unlikely milestone payments are included in TCV, despite not representing firm contractual commitments. The April 2025 Pathos deal, which accounts for $200 million of TCV, involves a company founded, managed, and funded by Tempus leadership and Board-related investment firms, raising related-party and conflict-of-interest concerns. We also believe the SoftBank JV allowed Tempus to recognize $95 million in TCV which is precisely the amount of capital Tempus contributed. Key strategic partnerships and deal announcement with AstraZeneca and Pathos AI merit scrutiny. Tempus's partnership with AstraZeneca began in November 2021 with the announcement of a five-year, $200 million Master Services Agreement ('MSA'), which was positioned as a cornerstone relationship for the Company. Over time, this agreement was amended to extend the term to nearly seven years and increase the total commitment to $220 million. However, beneath the surface, we believe the partnership has weakened and is based on suspicious economic considerations: 1) AstraZeneca ultimately declined to increase its commitment before the end of 2024, forfeiting a warrant to purchase $100 million of TEM stock at the IPO price one year before expiry. We believe this refusal signaled AstraZeneca's reluctance to deepen its financial stake and pointed to a deterioration in the strength of the relationship, despite public messaging that suggests otherwise, and 2) a provision links AstraZeneca's increased potential commitment to a doubling of TEM's share price and not to actual demand for, or perceived value from, the products and services delivered by Tempus. This provision does not, in our opinion, hold up under scrutiny. Pathos AI ('Pathos') is a Lefkofsky-related company being touted as a unicorn with a $1.6 billion valuation. Ironically, Tempus already owns warrants to purchase 15% of Pathos, but internally appears to ascribe it as worthless on the balance sheet and appointed a Chief Scientist who was the founding CEO of Sema4 (now GeneDx). According to a recent report by Grizzly Research entitled 'Insiders Attest That GeneDx Is Actively Committing Widespread Fraud', CEO Schadt was aware that the company was billing insurance providers for tests without sufficient evidence to support the charges. In late April 2025, Tempus promoted 'Expanded Strategic Agreements with AstraZeneca and Pathos' which we believe embodies the extreme financial engineering now characterizing recent deals. Public statements could lead investors to believe this was an incremental, expanded contract from AstraZeneca. We believe the $35 million payment from AstraZeneca to Tempus is not new revenue, but rather a pass-through payment that Tempus is contractually obligated to forward to Pathos as a "Statement of Work" under the original 2021 MSA. In other words, it was already part of AstraZeneca's existing contractual commitment. By routing these funds to Pathos, we believe AstraZeneca reduced its remaining obligation to Tempus by $35 million and thus was not an expansion of its partnership. The $200 million data licensing and model development deal raises profound conflict-of-interest concerns and calls into question the independence and economic substance of this headline contract. Up to half of the $200 million may be paid in illiquid Pathos Series D Preferred Stock - not cash - and Tempus is required to pay Pathos $35 million as part of the same arrangement. This convoluted structure, involving related parties and non-cash consideration, raises serious questions about the authenticity of the Company's reported revenue and backlog. Far from being a true extension of the AstraZeneca relationship, we believe the Pathos deal underscores a weaker commitment from a significant customer, while highlighting a reliance on related-party transactions and creative deal structuring. We believe the Company's recent financial guidance revision reveals weakness in core operations. We believe that the $10 million FY25 revenue guidance increase earlier this month is substantially explained by the expected contributions from the Ambry Genetics acquisition and the new Pathos/AstraZeneca deal, two factors that we estimate should have added nearly $46 million to projected revenue for the year. With overall guidance rising by only a fraction of this amount, we believe it reveals a significant shortfall in the core genomics and data businesses. This discrepancy strongly suggests that the Company's fundamental operations are underperforming relative to prior expectations. It further supports the view that headline growth is being driven by acquisitions, related-party transactions, and financial maneuvers, rather than by robust organic growth in its main business lines. There are other indicators of a deterioration in business such as an exhaustion of nearly all long-term deferred revenue and a decline in the growth rate of cloud storage costs as well as a recent amendment to the Google contract. We believe that owning shares of Tempus is a poor risk / reward. We believe the Tempus equity growth story is built on hype and an appeal to retail investors that it is an exciting and disruptive technology play with AI appeal which could have the next Tesla- or Nvidia-type inflection. However, we think investors should focus on its aggressive accounting, financial engineering, related party dealings, and earnings quality. Tempus is extremely dependent on keeping the perceived value of its equity high because it is among the most aggressive issuers among its peers of stock-based compensation at 77% of revenue. Key insiders and early institutional investors have quickly begun to liquidate stock while its shares command a premium multiple based on its above-industry average revenue growth irrespective of its source and quality. Debt is now rising from the Ambry Genetics acquisition, and we find an unusual financial covenant for a $12 billon public company which requires the Company to maintain a minimum of $1 billion in revenue which we believe puts greater pressure on the Company to be creative in seeking new business. Given these risks, we believe that investors should exercise extreme caution and scrutinize the Company's public statements closely. The sell-side consensus price target is $66.82 per share which implies just 1% upside potential. We value the core, related party, and acquired revenues of Tempus separately and based on our 2025E estimates, we see 50% – 60% potential downside risk to TEM's share price. As a result, we do not see a favorable risk / reward in owning the stock and expect shares to underperform the medical diagnostics industry along with the broader equity market. Please note that the items summarized in this press release are expanded upon and supported with data, public filings and records, and images in Spruce Point's full report. As a reminder, our full report, along with its investment disclaimers, can be downloaded and viewed at As disclosed, Spruce Point and/or its clients have a short position in Tempus AI, Inc. (Nasdaq: TEM) and owns derivative securities that stand to net benefit if its share price falls. Following publication of the report, we intend to continue transacting in the securities covered therein, and we may be long, short, or neutral at any time hereafter regardless of our initial opinion. For additional important information, please review the 'Full Legal Disclaimer' contained in the report. Spruce Point Capital Management, LLC is a forensic fundamentally-oriented investment manager that focuses on short-selling, value and special situation investment opportunities.
Indianapolis Star
4 days ago
- Business
- Indianapolis Star
We found a new Costco deal: Join now, get a free $50 Costco Shop Card
From exclusive savings on groceries and household essentials to invaluable discounts on gas and travel, a Costco membership can help you save all year long. And of course, no mention of Costco is complete without the legendary $1.50 hot dog and soda combo—a fan-favorite that's held strong for over 40 years (and hopefully 40 more!). The USA TODAY Shopping team loves to dig up deals for our readers and honestly, this is one of my favorites. Here's the deal: Groupon has a new offer on Costco memberships that includes a free $50 Costco Shop Card when you sign up for the Gold Star or Executive tier memberships, plus travel perks and an extra $100 off a order of $200 or more when you sign up for an Executive membership. Learn more below and check out other offers at Groupon. Get a free Costco Shop Card on Groupon Now through Sunday, June 22, you can get an annual Gold Star Costco membership on Groupon for $65 and receive a $50 free digital Costco Shop Card to use on future purchases at any Costco location or online. You can also get the Costco Executive Membership Package for $130 and receive the same $50 Costco Shop Card and $200 Digital Costco Shop Card for Costco Travel, PLUS an additional perk of $100 off a order of $200 or more! The special Groupon offer is valid for new members or previous Costco cardholders whose membership has been expired for at least 18 months. The $65 Gold Star Membership is a better option for individuals or families who shop at Costco on an occasional basis or do not require the additional benefits of the Executive Membership. With a lower annual fee, this membership includes access to Costco's wide range of products and services, making it a cost-effective choice for those who do not have substantial spending at Costco each year. Get a free $50 Costco Shop Card The $130 Executive Membership is ideal for frequent Costco shoppers, offering a 2% annual reward and additional benefits. For those who spend more than $3,000 annually at Costco, the Executive Membership includes major savings through exclusive discounts and promotions. The higher annual fee is counterbalanced by the rewards and benefits, making it a practical option for regular Costco customers. Get a free $50 Costco Shop Card After you complete your purchase on Groupon's website, you'll receive an email from Costco confirming your membership details. Groupon says to allow up to two hours to receive your confirmation email. Your Costco Shop Card will be emailed within two weeks after sign-up to qualifying members. A physical membership card is not required to shop online or receive your included gift card. To receive a physical membership card, visit the membership counter at your preferred Costco location. ➤Pro-tip: Remember to bring a photo ID with a copy of your Costco or Groupon confirmation email. The famous $1.50 Costco hot dog has been available in Costco food courts since 1984. The price has never increased and Costco's CFO assured customers that the price would not be impacted by inflation.
USA Today
4 days ago
- Entertainment
- USA Today
Banish summer boredom and save up to 50% with these epic summer toys and pools
Banish summer boredom and save up to 50% with these epic summer toys and pools Splash into fun all summer long! With warm weather upon us and summer break just around the corner, your kids will soon be home and, inevitably, complaining about being bored. While you can certainly check Groupon for tickets and discounts on local activities like zoo passes and trampoline parks, even the most well-intentioned parents can't do that every day. So, if you want to keep your kids entertained and hopefully give them a much-needed (but necessarily wanted) break from screens, there are a couple of things that might help. An inflatable water ski float with an attached water shooter might inspire them to spend more time in the pool, a hose accessory attachment for the trampoline could give them a fun way to get some energy out or even your older kiddos might spend more time outside with this backyard water pong set. No pool? No worries, we have summer fun for everyone! We've compiled some top deals for summer toys below to help avoid that dreadful 'Mom, I'm bored' talk. Here's a quick way to browse our top categories: Top toy deals for summer to keep your kids entertained: More: Grab these sizzling grill and pizza oven deals just in time for summer at Lowe's, Gozney For your slightly older kiddos, or just for something different, try this water and sand table that looks like a racetrack from Target! More: HeyDude brings back its best-selling Margaritaville collab just in time for summer ☀️ More: Hate bugs? Get up to 43% off Thermacell mosquito and tick repellent for Memorial Day More: 🇺🇸 Don't miss out on today's top Memorial Day sales!
